Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.17
+0.08 (1.13%)
Nov 5, 2024, 10:57 AM EST - Market open
Kezar Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 52 | 69 | 481 | 822 | 242 | 77 | |
| Market Cap Growth | -75.38% | -85.69% | -41.42% | 240.23% | 214.65% | -82.98% | |
| Enterprise Value | -95 | -130 | 204 | 706 | 97 | -2 | |
| Last Close Price | 7.09 | 9.47 | 70.40 | 167.20 | 52.20 | 40.10 | |
| PE Ratio | - | -0.67 | -6.95 | -16.15 | -5.50 | -2.18 | |
| PS Ratio | 7.37 | 9.84 | - | - | - | - | |
| PB Ratio | 0.34 | 0.37 | 1.78 | 4.17 | 1.71 | 0.98 | |
| P/FCF Ratio | -0.55 | -0.83 | -7.97 | -19.22 | -6.50 | -2.52 | |
| P/OCF Ratio | -0.55 | -0.84 | -8.18 | -19.36 | -6.54 | -2.57 | |
| EV/Sales Ratio | -16.83 | -18.54 | - | - | - | - | |
| EV/EBITDA Ratio | 1.20 | 1.25 | -2.91 | -13.28 | -2.35 | 0.05 | |
| EV/EBIT Ratio | 1.18 | 1.23 | -2.87 | -12.91 | -2.26 | 0.05 | |
| EV/FCF Ratio | 1.49 | 1.56 | -3.38 | -16.51 | -2.62 | 0.06 | |
| Debt / Equity Ratio | 0.12 | 0.10 | 0.08 | 0.07 | 0.04 | 0.08 | |
| Debt / FCF Ratio | -0.22 | -0.23 | -0.35 | -0.33 | -0.15 | -0.21 | |
| Asset Turnover | 0.03 | 0.03 | - | - | - | - | |
| Quick Ratio | 9.48 | 11.48 | 25.22 | 25.37 | 21.92 | 13.13 | |
| Current Ratio | 9.58 | 11.66 | 25.98 | 25.77 | 22.48 | 13.52 | |
| Return on Equity (ROE) | -51.48% | -44.54% | -29.24% | -32.34% | -38.12% | -37.56% | |
| Return on Assets (ROA) | -28.07% | -25.26% | -17.19% | -18.48% | -22.24% | -22.86% | |
| Return on Capital (ROIC) | -29.57% | -26.43% | -17.72% | -19.12% | -23.26% | -24.16% | |
| Earnings Yield | -190.54% | -147.92% | -14.18% | -6.65% | -17.28% | -45.71% | |
| FCF Yield | -153.13% | -121.18% | -12.55% | -5.20% | -15.38% | -39.71% | |
| Buyback Yield / Dilution | -0.60% | -7.70% | -27.69% | -19.90% | -130.58% | -85.92% | |
| Total Shareholder Return | -0.60% | -7.70% | -27.69% | -19.90% | -130.58% | -85.92% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.